Drug
Vaccination With Acam2000
Vaccination With Acam2000: highest development phase Post-Market, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vaccination with ACAM2000 NCT02443623 | Post-Market | Smallpox Vaccine Adverse Reaction |
Latest
No recent events.
Follow Vaccination With Acam2000 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.